{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T22:59:24Z","timestamp":1770505164885,"version":"3.49.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2007,8,22]],"date-time":"2007-08-22T00:00:00Z","timestamp":1187740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2007,8,22]],"date-time":"2007-08-22T00:00:00Z","timestamp":1187740800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clinic Rev Allerg Immunol"],"published-print":{"date-parts":[[2008,2]]},"DOI":"10.1007\/s12016-007-8025-2","type":"journal-article","created":{"date-parts":[[2007,8,21]],"date-time":"2007-08-21T14:00:22Z","timestamp":1187704822000},"page":"80-84","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Combined Therapy with Rituximab Plus Cyclophosphamide\/Vincristine\/Prednisone for Sjogren\u2019s Syndrome-Associated B-Cell Non-Hodgkin\u2019s Lymphoma"],"prefix":"10.1007","volume":"34","author":[{"given":"J.","family":"Carbone","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Perez-Fernandez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Sabin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Carre\u00f1o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Fernandez-Cruz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,8,22]]},"reference":[{"key":"8025_CR1","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1136\/ard.61.6.554","volume":"61","author":"C Vitali","year":"2002","unstructured":"Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, Daniels TE, Fox PC, Fox RI, Kassan SS, Pillemer SR, Talal N, Weisman MH (2002) Classification criteria for Sjogren\u2019s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 61:554\u2013558","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"8025_CR2","first-page":"438","volume":"24","author":"P Manganelli","year":"2006","unstructured":"Manganelli P, Fietta P, Quaini F (2006) Hematologic manifestations of primary Sjogren\u2019s syndrome. Clin Exp Rheumatol 24(4):438\u2013448","journal-title":"Clin Exp Rheumatol"},{"issue":"5","key":"8025_CR3","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1002\/art.1780390508","volume":"39","author":"AG Tzioufas","year":"1996","unstructured":"Tzioufas AG, Boumba DS, Skopouli FN, Moutsopoulos HM (1996) Mixed monoclonal cryoglobulinemia and monoclonal rheumatoid factor crossreactive idiotypes as predictive factors for the development of lymphoma in primary Sjogren\u2019s syndrome. Arthritis Rheum 39(5):767\u2013772","journal-title":"Arthritis Rheum"},{"issue":"8","key":"8025_CR4","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1002\/1529-0131(199908)42:8<1765::AID-ANR28>3.0.CO;2-V","volume":"42","author":"M Voulgarelis","year":"1999","unstructured":"Voulgarelis M, Dafni UG, Isenberg DA, Moutsopoulos HM by the European Concerted Action on Sjogren\u2019s Syndrome (1999) Malignant lymphoma in primary Sjogren\u2019s syndrome: a multicenter, retrospective, clinical study by the European Concerted Action on Sjogren\u2019s Syndrome. Arthritis Rheum 42(8):1765\u20131772","journal-title":"Arthritis Rheum"},{"issue":"5","key":"8025_CR5","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1182\/blood.V100.5.1648.h81702001648_1648_1654","volume":"100","author":"JI Chacon","year":"2002","unstructured":"Chacon JI, Mollejo M, Mu\u00f1oz E, Algara P, Mateo M, Lopez L, Andrade J, Garcia Carbonero I, Martinez B, Piris MA, Cruz MA (2002) Splenic marginal zone lymphoma: clinical characteristics and prognostic factors in a series of 60 patients. Blood 100(5):1648\u20131654","journal-title":"Blood"},{"key":"8025_CR6","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1200\/JCO.1999.17.1.268","volume":"17","author":"MS Czuczman","year":"1999","unstructured":"Czuczman MS, Grillo-Lopez AJ, White CA, Saleh M, Gordon L, LoBuglio AF, Jonas C, Klippenstein D, Dallaire B, Varns C (1999) Treatment of patients with low-grade B-cell lymphoma with the combination of chimeric anti-CD20 monoclonal antibody and CHOP chemotherapy. J Clin Oncol 17:268\u2013276","journal-title":"J Clin Oncol"},{"issue":"3","key":"8025_CR7","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1136\/ard.2006.057919","volume":"66","author":"R Seror","year":"2007","unstructured":"Seror R, Sordet C, Guillevin L, Hachulla E, Masson C, Ittah M, Candon S, Leguern V, Aouba A, Jean S, Gottenberg JE, Mariette X (2007) Tolerance and efficacy of rituximab and changes in serum B cell biomarkers in patients with systemic complications of primary Sjogren\u2019s syndrome. Ann Rheum Dis 66(3):351\u2013357","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"8025_CR8","doi-asserted-by":"publisher","first-page":"2740","DOI":"10.1002\/art.21260","volume":"52","author":"J Pijpe","year":"2005","unstructured":"Pijpe J, van Imhoff GW, Spijkervet FK, Roodenburg JL, Wolbink GJ, Mansour K, Vissink A, Kallenberg CG, Bootsma H (2005) Rituximab treatment in patients with primary Sjogren\u2019s syndrome: an open-label phase II study. Arthritis Rheum 52(9):2740\u20132750","journal-title":"Arthritis Rheum"},{"key":"8025_CR9","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1159\/000082102","volume":"8","author":"MS Cragg","year":"2005","unstructured":"Cragg MS (2005) The biology of CD20 and its potential as a target for mAb therapy. Curr Dir Autoimmun 8:140\u2013174","journal-title":"Curr Dir Autoimmun"},{"issue":"1 Suppl 1","key":"8025_CR10","doi-asserted-by":"publisher","first-page":"S19","DOI":"10.1053\/j.seminoncol.2005.01.010","volume":"32","author":"DG Maloney","year":"2005","unstructured":"Maloney DG (2005) Concepts in radiotherapy and immunotherapy: anti-CD20 mechanisms of action and targets. Semin Oncol 32(1 Suppl 1):S19\u2013S26","journal-title":"Semin Oncol"},{"issue":"4","key":"8025_CR11","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.4049\/jimmunol.178.4.2287","volume":"15","author":"AJ Stel","year":"2007","unstructured":"Stel AJ, Ten Cate B, Jacobs S, Kok JW, Spierings DC, Dondorff M, Helfrich W, Kluin-Nelemans HC, de Leij LF, Withoff S, Kroesen BJ (2007) Fas receptor clustering and involvement of the death receptor pathway in rituximab-mediated apoptosis with concomitant sensitization of lymphoma B cells to fas-induced apoptosis. J Immunol 15;178(4):2287\u20132295","journal-title":"J Immunol"},{"key":"8025_CR12","doi-asserted-by":"crossref","unstructured":"Marcus R, Hagenbeek A (2007) The therapeutic use of rituximab in non-Hodgkin\u2019s lymphoma. Eur J Haematol Suppl (67):5\u201314","DOI":"10.1111\/j.1600-0609.2006.00789.x"},{"issue":"4","key":"8025_CR13","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1182\/blood-2004-08-3175","volume":"105","author":"R Marcus","year":"2005","unstructured":"Marcus R, Imrie K, Belch A, Cunningham D, Flores E, Catalano J, Solal-Celigny P, Offner F, Walewski J, Raposo J, Jack A, Smith P (2005) CVP chemotherapy plus rituximab compared with CVP as first-line treatment for advanced follicular lymphoma. Blood 105(4):1417\u20131423","journal-title":"Blood"},{"issue":"7","key":"8025_CR14","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1200\/JCO.2005.05.004","volume":"23","author":"JD Hainsworth","year":"2005","unstructured":"Hainsworth JD, Litchy S, Morrissey LH, Andrews MB, Grimaldi M, McCarty M, Greco FA (2005) Rituximab plus short-duration chemotherapy as first-line treatment for follicular non-Hodgkin\u2019s lymphoma: a phase II trial of the Minnie Pearl Cancer Research Network. J Clin Oncol 23(7):1500\u20131506","journal-title":"J Clin Oncol"},{"issue":"8","key":"8025_CR15","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1136\/ard.2005.046193","volume":"65","author":"M Voulgarelis","year":"2006","unstructured":"Voulgarelis M, Giannouli S, Tzioufas AG, Moutsopoulos HM (2006) Long term remission of Sjogren\u2019s syndrome associated aggressive B cell non-Hodgkin\u2019s lymphomas following combined B cell depletion therapy and CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone). Ann Rheum Dis 65(8):1033\u20131037","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"8025_CR16","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1093\/rheumatology\/keh248","volume":"43","author":"M Voulgarelis","year":"2004","unstructured":"Voulgarelis M, Giannouli S, Anagnostou D, Tzioufas AG (2004) Combined therapy with rituximab plus cyclophosphamide\/doxorubicin\/vincristine\/prednisone (CHOP) for Sjogren\u2019s syndrome-associated B-cell aggressive non-Hodgkin\u2019s lymphomas. Rheumatology (Oxford) 43(8):1050\u20131053","journal-title":"Rheumatology (Oxford)"},{"issue":"12","key":"8025_CR17","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1191\/0961203304lu2049xx","volume":"13","author":"M Ramos-Casals","year":"2004","unstructured":"Ramos-Casals M, Lopez-Guillermo A, Brito-Zeron P, Cervera R, Font J (2004) Treatment of B-cell lymphoma with rituximab in two patients with Sjogren\u2019s syndrome associated with hepatitis C virus infection. Lupus 13(12):969\u2013971","journal-title":"Lupus"},{"issue":"6","key":"8025_CR18","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1136\/ard.2004.030684","volume":"64","author":"J Pijpe","year":"2005","unstructured":"Pijpe J, van Imhoff GW, Vissink A, van der Wal JE, Kluin PM, Spijkervet FK, Kallenberg CG, Bootsma H (2005) Changes in salivary gland immunohistology and function after rituximab monotherapy in a patient with Sjogren\u2019s syndrome and associated MALT lymphoma. Ann Rheum Dis 64(6):958\u2013960","journal-title":"Ann Rheum Dis"},{"key":"8025_CR19","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1136\/ard.2004.029694","volume":"64","author":"JE Gottenberg","year":"2005","unstructured":"Gottenberg JE, Guillevin L, Lambotte O, Combe B, Allanore Y, Cantagrel A, Larroche C, Soubrier M, Bouillet L, Dougados M, Fain O, Farge D, Kyndt X, Lortholary O, Masson C, Moura B, Remy P, Thomas T, Wendling D, Anaya JM, Sibilia J, Mariette X (2005) Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune diseases. Ann Rheum Dis 64:913\u2013920","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"8025_CR20","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1093\/rheumatology\/keh308","volume":"43","author":"KC Harner","year":"2004","unstructured":"Harner KC, Jackson LW, Drabick JJ (2004) Normalization of anticardiolipin antibodies following rituximab therapy for marginal zone lymphoma in a patient with Sjogren\u2019s syndrome. Rheumatology (Oxford) 43(10):1309\u20131310","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"8025_CR21","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/art.11109","volume":"15","author":"BG Somer","year":"2003","unstructured":"Somer BG, Tsai DE, Downs L, Weinstein B, Schuster SJ (2003) Improvement in Sjogren\u2019s syndrome following therapy with rituximab for marginal zone lymphoma. Arthritis Rheum 15;49(3):394\u2013398","journal-title":"Arthritis Rheum"},{"issue":"2","key":"8025_CR22","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1097\/00003072-200202000-00019","volume":"27","author":"WJ Shih","year":"2002","unstructured":"Shih WJ, Ghesani N, Hongming Z, Alavi A, Schusper S, Mozley D (2002) F-18 FDG positron emission tomography demonstrates resolution of non-Hodgkin\u2019s lymphoma of the parotid gland in a patient with Sjogren\u2019s syndrome: before and after anti-CD20 antibody rituximab therapy. Clin Nucl Med 27(2):142\u2013143","journal-title":"Clin Nucl Med"},{"key":"8025_CR23","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/S0952-7915(02)00356-4","volume":"14","author":"RA Manz","year":"2002","unstructured":"Manz RA, Arce S, Cassese G, Hauser AE, Hiepe F, Radbruch A (2002) Humoral immunity and long-lived plasma cells. Curr Opin Immunol 14:517\u2013521","journal-title":"Curr Opin Immunol"},{"issue":"11","key":"8025_CR24","doi-asserted-by":"publisher","first-page":"3580","DOI":"10.1002\/art.20592","volume":"50","author":"JH Anolik","year":"2004","unstructured":"Anolik JH, Barnard J, Cappione A, Pugh-Bernard AE, Felgar RE, Looney RJ, Sanz I (2004) Rituximab improves peripheral B cell abnormalities in human systemic lupus erythematosus. Arthritis Rheum 50(11):3580\u20133590","journal-title":"Arthritis Rheum"},{"issue":"2","key":"8025_CR25","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1157\/13072916","volume":"33","author":"E Sarmiento","year":"2005","unstructured":"Sarmiento E, Mora R, Rodriguez-Mahou M, Rodriguez-Molina J, Fernandez-Cruz E, Carbone J (2005) Autoimmune disease in primary antibody deficiencies. Allergol Immunopathol (Madr) 33(2):69\u201373","journal-title":"Allergol Immunopathol (Madr)"},{"issue":"3","key":"8025_CR26","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1002\/ajh.10050","volume":"69","author":"C Cunningham-Rundles","year":"2002","unstructured":"Cunningham-Rundles C, Cooper DL, Duffy TP, Strauchen J (2002) Lymphomas of mucosal-associated lymphoid tissue in common variable immunodeficiency. Am J Hematol 69(3):171\u2013178","journal-title":"Am J Hematol"},{"issue":"2","key":"8025_CR27","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1002\/ajh.2830370202","volume":"37","author":"C Cunningham-Rundles","year":"1991","unstructured":"Cunningham-Rundles C, Lieberman P, Hellman G, Chaganti RS (1991) Non-Hodgkin lymphoma in common variable immunodeficiency. Am J Hematol 37(2):69\u201374","journal-title":"Am J Hematol"},{"issue":"2","key":"8025_CR28","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1080\/10428190500285285","volume":"47","author":"A Aghamohammadi","year":"2006","unstructured":"Aghamohammadi A, Parvaneh N, Tirgari F, Mahjoob F, Movahedi M, Gharagozlou M, Mansouri M, Kouhi A, Rezaei N, Webster D (2006) Lymphoma of mucosa-associated lymphoid tissue in common variable immunodeficiency. Leuk Lymphoma 47(2):343\u2013346","journal-title":"Leuk Lymphoma"},{"issue":"2","key":"8025_CR29","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1046\/j.1365-2249.2003.02253.x","volume":"134","author":"MM Gompels","year":"2003","unstructured":"Gompels MM, Hodges E, Lock RJ, Angus B, White H, Larkin A, Chapel HM, Spickett GP, Misbah SA, Smith JL (2003) Lymphoproliferative disease in antibody deficiency: a multi-centre study. Clin Exp Immunol 134(2):314\u2013320","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"8025_CR30","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1006\/clin.1994.1011","volume":"70","author":"P Eriksson","year":"1994","unstructured":"Eriksson P, Almroth G, Denneberg T, Lindstrom FD (1994) IgG2 deficiency in primary Sjogren\u2019s syndrome and hypergammaglobulinemic purpura. Clin Immunol Immunopathol 70(1):60\u201365","journal-title":"Clin Immunol Immunopathol"}],"container-title":["Clinical Reviews in Allergy &amp; Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-007-8025-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12016-007-8025-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-007-8025-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-007-8025-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T11:02:14Z","timestamp":1659092534000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12016-007-8025-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8,22]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,2]]}},"alternative-id":["8025"],"URL":"https:\/\/doi.org\/10.1007\/s12016-007-8025-2","relation":{},"ISSN":["1080-0549","1559-0267"],"issn-type":[{"value":"1080-0549","type":"print"},{"value":"1559-0267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,8,22]]},"assertion":[{"value":"22 August 2007","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}